AAV's anatomy: roadmap for optimizing vectors for translational success - Test2 - elhamkhani - TriplyDB

AAV's anatomy: roadmap for optimizing vectors for translational success

AAV's anatomy: roadmap for optimizing vectors for translational success

http://www.wikidata.org/entity/Q33659389

about

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate Adeno-associated Virus as a Mammalian DNA Vector Ultramicroscopy as a novel tool to unravel the tropism of AAV gene therapy vectors in the brain Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis.Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.Efficient transduction and optogenetic stimulation of retinal bipolar cells by a synthetic adeno-associated virus capsid and promoter.Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms Terminal N-linked galactose is the primary receptor for adeno-associated virus 9.Characterization of naturally-occurring humoral immunity to AAV in sheep.Effects of angiotensin II type 2 receptor overexpression on the growth of hepatocellular carcinoma cells in vitro and in vivo.The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5.Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B).Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.Retinal Gene Therapy: Current Progress and Future Prospects.Center for fetal monkey gene transfer for heart, lung, and blood diseases: an NHLBI resource for the gene therapy community.Arsenic trioxide stabilizes accumulations of adeno-associated virus virions at the perinuclear region, increasing transduction in vitro and in vivo.Adeno-associated virus-mediated rescue of neonatal lethality in argininosuccinate synthetase-deficient mice Mechanistic insights into the enhancement of adeno-associated virus transduction by proteasome inhibitors.Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.Oversized AAV transductifon is mediated via a DNA-PKcs-independent, Rad51C-dependent repair pathway.Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication.Recombinant adeno-associated virus utilizes host cell nuclear import machinery to enter the nucleus Recombinant Adeno-Associated Virus-Mediated Expression of Methamphetamine Antibody Attenuates Methamphetamine-Induced Hyperactivity in Mice.Gene and cell therapy based treatment strategies for inflammatory bowel diseases.Targeted gene therapies: tools, applications, optimization Update on gene and stem cell therapy approaches for spinal muscular atrophy.Gene therapy for heart failure: where do we stand?Peptide affinity reagents for AAV capsid recognition and purification Cystic fibrosis: a look into the future of prenatal screening and therapy.Gene therapy for age-related macular degeneration.Thymosin Beta-4 Recombinant Adeno-associated Virus Enhances Human Nucleus Pulposus Cell Proliferation and Reduces Cell Apoptosis and Senescence.Neutralizing antibodies against adeno-associated virus examined prospectively in pediatric patients with hemophilia.Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.Glycated AAV vectors: chemical redirection of viral tissue tropism.AAV-mediated gene editing via double-strand break repair Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes.Gene therapy for inherited retinal and optic nerve degenerations.Experimental Gene Therapy with Serine-Histogranin and Endomorphin 1 for the Treatment of Chronic Neuropathic Pain.

P2860

Q24288709-AA249D74-BE2B-433C-8381-540A07D8A24B Q26782605-B36FE376-A5F1-4229-9EFB-A86E7342874F Q27335825-53676239-55A0-467B-9C00-CA0C7FB88CA9 Q28071453-AA005487-047C-45B9-8F68-A08491076558 Q30537079-A2AEAB76-BE88-4F06-97AE-005FF8421BC1 Q33833473-DE79C0FE-87B6-41C8-99D2-F4264464F61A Q34342494-392D655C-4162-48EE-BB6C-0829727B3E74 Q34593758-AFFDC6B1-D8E4-4D23-855D-8211F5EE493F Q34787342-88AC0DF0-1A96-4B41-AB14-3919ACBFDDC0 Q35005408-65784F08-87AA-460D-930A-54A5D69F23A7 Q35082610-5DB512DB-E195-4845-9B11-D573F1852AE3 Q35341751-06E1A07A-74D7-40BB-8E8B-FD6DA1843E7A Q35661179-CA9FD0D2-EC2C-441A-85FE-29737695FC2A Q36171849-1C98C006-5EC1-4D8E-9B83-A0902C62A480 Q36306263-3EE6AF1E-92A1-4172-88D4-934B379C90C8 Q36401337-E9F55EFC-7C21-4008-AC51-F30BB736FE4F Q36760126-0AE0A017-11A7-4230-830F-EB00F5E42AF6 Q37254867-01BF7283-3979-4C4C-921B-8583B228043E Q37336413-7CF134C3-E2D6-4A33-AF0B-35D4D26116DA Q37347354-67E917D3-5F2C-45A1-B6CA-D34798BFAD32 Q37393799-5E855590-1A79-4B7B-B151-093AAFC06D3F Q37547441-339FEB78-4832-4277-93C8-553DF2902A16 Q37713851-7477F472-3B1E-424A-9C95-99C7EA1CD960 Q37741250-153F69BB-9517-4578-B3AF-974BC230DF54 Q37969759-E2DDF58B-E781-4953-9DE9-244E962BD911 Q38005211-8205F674-BA66-4075-906D-81584B5E6109 Q38030978-8D7E981A-5D80-4567-87B6-F6D2160265DF Q38073152-84FB7213-7245-44E7-9E41-0EF2C45450B4 Q38335916-583C21C2-F6CA-4A25-950D-5D2D9B05903F Q38395133-AABD457F-0366-4F7F-BDB2-CF560A74F89B Q38654588-4CFE192B-6059-43C3-A20D-9049DD56A909 Q38869952-EF9A8958-1B4C-441F-88AB-A6E19D40FA53 Q39519818-D4BAD294-9B0A-469D-B1C5-187BF18A036B Q41093443-BD5B2010-36FD-4856-BBEC-1C2C1C2F7945 Q42093895-28CCEBA5-127B-424F-9687-D45BFF052526 Q42235951-5DD45AAB-5BBA-412B-90AB-D1437335285C Q43545330-1065D798-63BB-4380-A59F-CB923D5E0659 Q45873452-EECD47D2-AB48-4BA3-9DAB-621391247861 Q47131605-28FEE064-A550-46C8-8724-8E933550297B

P2860

AAV's anatomy: roadmap for optimizing vectors for translational success

http://www.wikidata.org/entity/Q33659389

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

AAV's anatomy: roadmap for optimizing vectors for translational success

@ast

AAV's anatomy: roadmap for optimizing vectors for translational success

@en

type

label

AAV's anatomy: roadmap for optimizing vectors for translational success

@ast

AAV's anatomy: roadmap for optimizing vectors for translational success

@en

prefLabel

AAV's anatomy: roadmap for optimizing vectors for translational success

@ast

AAV's anatomy: roadmap for optimizing vectors for translational success

@en

P1433

Q33659389-98DB40AB-32B0-4864-BD92-AC8C3E8CA687

P1476

Q33659389-0CF56B37-7834-45F6-BF1D-28664900E5C1

P2093

Q33659389-16B51AB7-6CE8-4EBA-9D68-0BE277FC2B48

Q33659389-5AF087B6-3107-40A2-B780-6039F4D0CD42

Q33659389-9A6F7165-3E89-4198-90E2-D072CE2FE7EB

Q33659389-BEB9600D-59ED-4A18-88A0-65AFD53EAB53

P2860

Q33659389-01A83992-7900-443D-81BA-846174464E35

Q33659389-031538D6-3644-4937-AB4D-9B4E8E063394

Q33659389-03D36E86-0C3B-46D2-8033-FB80355DB159

Q33659389-046C3705-556E-4139-94C8-8F934F08DE15

Q33659389-051C9D68-0722-486C-BA6B-EE891A0400C0

Q33659389-062F4B8A-A1F1-434F-AD03-49724E7DE2B6

Q33659389-078F40A5-B8D7-46B6-B57B-D63554C64138

Q33659389-08363717-783E-4DB0-8E20-CAC2CAB3AAD1

Q33659389-0B3F5E03-9038-4D0A-8575-0F4303ACF962

Q33659389-0D178A7B-65B5-44BD-9ADF-F7BFE187A011

P304

Q33659389-2EE2EDEF-0F0C-463D-9DD6-CC9096D5B9D2

P31

Q33659389-E9E76AD4-5C51-4FEA-B14F-F0034FEBF98A

P356

Q33659389-C03BB743-4E69-4DD6-A93B-5D7FF88F361E

P407

Q33659389-5F6C940A-14F9-4437-8D0B-6253BA548EBA

P433

Q33659389-AEAE675E-CE43-47CE-8DB9-B9F17536BD97

P478

Q33659389-4657AA1B-0C35-48D5-803B-4366F4CBB152

P577

Q33659389-4A82FF64-E1B1-4967-8DE6-E20D03A21117

P698

Q33659389-42604DE4-B70C-4251-8B31-D173B23674CF

P932

Q33659389-0C4C4C30-2F69-4EE0-A693-8C259D902164

P356

156652310793180706

P1433

Current Gene Therapy

P1476

AAV's anatomy: roadmap for optimizing vectors for translational success

@en

P2093

Angela M Mitchell

http://www.w3.org/2001/XMLSchema#string

Jayme K Warischalk

http://www.w3.org/2001/XMLSchema#string

R Jude Samulski

http://www.w3.org/2001/XMLSchema#string

Sarah C Nicolson

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Baculovirus-mediated gene delivery into Mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression.

Site-specific integration by adeno-associated virus

DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution

Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus

Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups

Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1

P304

319-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/156652310793180706

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20712583

http://www.w3.org/2001/XMLSchema#string

P932

3920455

http://www.w3.org/2001/XMLSchema#string